Investor group comments on pasithea therapeutics' seemingly defensive and ill-timed acquisition of allomek therapeutics

New york & toronto--(business wire)--camac partners, llc, affiliates of concord investment partners ltd.

KTTA Ratings Summary

KTTA Quant Ranking